Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 69Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 7Lung Neoplasms 4Non-Squamous Non-Small Cell Lung Cancer 3Neoplasms 3Recurrent Squamous Cell Lung Carcinoma 1Pancreatic Neoplasms 1Nonsquamous Nonsmall Cell Neoplasm of Lung 1Neoplasm Metastasis 1NSCLC 1

Interventions

Blood Specimen Collection 17Pancreaticoduodenectomy 15Surveys and Questionnaires 11Endoscopic Ultrasound-Guided Fine Needle Aspiration 10Observation 9Biopsy 8Specimen Handling 6Pancreatectomy 6Gemcitabine 6Endosonography 6Data Collection 6Surgical Procedures, Operative 5Magnetic Resonance Spectroscopy 5Electroporation 5Biopsy, Fine-Needle 5Neoadjuvant Therapy 4Magnetic Resonance Imaging 4Liquid Biopsy 4Interviews as Topic 4Immunologic Techniques 4Immunohistochemistry 4Drug Therapy 4folfirinox 3Fluorouracil 3Cholangiopancreatography, Endoscopic Retrograde 3Albumin-Bound Paclitaxel 3irinotecan sucrosofate 2Taxes 2Sulfonylurea Compounds 2Secretin 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Pancreatic Neoplasms × Erlotinib Hydrochloride × Clear all
NCT01782690 2018-07-23

An Observational Study of Erlotinib Plus Gemcitabine in Patients With Metastatic Pancreatic Cancer

Hoffmann-La Roche

Completed
338 enrolled 18 charts
Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡